Clinic
Ihc Health Services, INC.
Ihc Health Services, INC. was paid $11.61M by Medicaid between Oct 2018 and Aug 2024, across 110 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 84% of everything it billed.
33Billing provider infoIHC HEALTH SERVICES, INC.
LAYTON, UT 84041
LAYTON, UT 84041
33aNPI1417460205assigned 11/15/2017
33bProvider typeSleep Disorder Diagnostic Clinic/Center
28Total paid$11.61M
24GClaims151,461
24DCodes billed110
24AFirst – last monthOct 2018 – Aug 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,439 | $138K | |
| 2019 | 23,118 | $1.46M | |
| 2020 | 31,446 | $2.16M | |
| 2021 | 45,149 | $3.35M | |
| 2022 | 47,375 | $4.32M | |
| 2023 | 2,658 | $175K | |
| 2024incomplete | 276 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 84% | 20,600 | 10,986 | $9.73M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 10,956 | 8,900 | $344K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 6,169 | 5,135 | $256K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.7% | 1,985 | 1,851 | $196K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 1.7% | 6,318 | 5,756 | $192K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,197 | 1,030 | $86K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,665 | 1,553 | $77K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | <1% | 7,343 | 6,438 | $73K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,352 | 3,575 | $55K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,004 | 939 | $36K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,262 | 3,682 | $35K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 3,564 | 3,158 | $30K |
98 more codes
| J2704 | Injection, propofol, 10 mg | <1% | 2,423 | $29K |
| 80050 | General health panel | <1% | 563 | $29K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,137 | $28K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,559 | $28K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 127 | $26K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,357 | $24K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 943 | $23K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 499 | $22K |
| 81001 | <1% | 5,280 | $21K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 675 | $19K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,314 | $18K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,745 | $14K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 635 | $14K |
| 80053 | Comprehensive metabolic panel | <1% | 9,459 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,084 | $12K |
| 85027 | <1% | 296 | $9K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 340 | $9K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 271 | $9K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,475 | $9K |
| 84702 | <1% | 2,338 | $8K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,982 | $7K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,058 | $7K |
| 96376 | <1% | 1,056 | $7K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 690 | $7K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,304 | $7K |
| 73630 | <1% | 120 | $6K | |
| 87081 | <1% | 422 | $5K | |
| 87186 | <1% | 642 | $5K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,360 | $5K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 901 | $5K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 745 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,151 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 232 | $4K |
| 86901 | <1% | 201 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 195 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,580 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,388 | $3K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 27 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 190 | $3K |
| 73610 | <1% | 56 | $2K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 15 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,564 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 39 | $2K |
| 87631 | <1% | 93 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 288 | $2K |
| 83880 | <1% | 331 | $2K | |
| 93971 | <1% | 99 | $2K | |
| 80047 | <1% | 39 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 70 | $2K |
| 83735 | <1% | 961 | $2K | |
| 83605 | <1% | 2,632 | $2K | |
| 84484 | <1% | 2,146 | $2K | |
| 84703 | <1% | 679 | $1K | |
| 73562 | <1% | 45 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 164 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 895 | $1K |
| 85379 | <1% | 739 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 434 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 78 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 117 | $918.62 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 176 | $681.11 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 83 | $679.69 |
| 83690 | <1% | 3,397 | $665.19 | |
| 74018 | <1% | 15 | $630.55 | |
| 73030 | <1% | 12 | $591.36 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $585.67 |
| 82565 | <1% | 164 | $552.52 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 395 | $510.59 |
| 87040 | <1% | 640 | $488.70 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 278 | $406.27 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 543 | $391.79 |
| 85610 | <1% | 528 | $319.06 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 13 | $304.65 |
| 76801 | <1% | 48 | $149.39 | |
| 87088 | <1% | 512 | $125.79 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 369 | $84.95 |
| 86140 | <1% | 1,207 | $64.79 | |
| 84100 | <1% | 57 | $64.07 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 603 | $63.71 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 95 | $31.17 |
| 86900 | <1% | 62 | $19.06 | |
| 83615 | <1% | 49 | $10.68 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 770 | $0.00 |
| 85651 | 0% | 239 | $0.00 | |
| 87070 | 0% | 14 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 54 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 68 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 15 | $0.00 |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 67 | $0.00 |
| 82803 | 0% | 96 | $0.00 | |
| 86850 | 0% | 56 | $0.00 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 12 | $0.00 |
| 82728 | 0% | 15 | $0.00 | |
| 84478 | 0% | 13 | $0.00 | |
| 84132 | 0% | 13 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 27 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 63 | $0.00 |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DENIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ihc Health Services, INC. | Murray, UT | $68.77M |
| Ihc Health Services, INC. | St George, UT | $65.78M |
| Ihc Health Services INC | Ogden, UT | $54.08M |
| Ihc Health Services, INC. | Provo, UT | $44.35M |
| Ihc Health Services INC | Logan, UT | $25.34M |
| Ihc Health Services, INC. | Cedar City, UT | $20.40M |
| Ihc Health Services, INC. | Salt Lake City, UT | $19.91M |
| Ihc Health Services, INC. | American Fork, UT | $17.19M |
| Ihc Health Services INC | Riverton, UT | $15.31M |
| Ihc Health Services INC | Sandy, UT | $11.66M |
| Ihc Health Services, INC. | Burley, ID | $5.14M |
| Ihc Health Services INC | Murray, UT | $4.64M |
| Ihc Health Services INC | St George, UT | $4.35M |
| Ihc Health Services INC | Heber City, UT | $4.31M |
| Ihc Health Services, INC. | Orem, UT | $4.18M |
| Ihc Health Services, INC. | Richfield, UT | $3.87M |
| Ihc Health Services INC | Tremonton, UT | $3.55M |
| Ihc Health Services, INC. | Spanish Fork, UT | $3.49M |
| Ihc Health Services INC | Park City, UT | $2.53M |
| Ihc Health Services, INC. | Mt Pleasant, UT | $2.34M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.